4530 — Hisamitsu Pharmaceutical Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapNeutral

Annual income statement for Hisamitsu Pharmaceutical Co, fiscal year end - February 29th, JPY millions except per share, conversion factor applied.

	2020 February 29th	2021 February 28th	2022 February 28th	2023 February 28th	2024 February 29th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	JAS	JAS	JAS	JAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	140,992	114,510	120,193	128,330	141,706
Cost of Revenue
Gross Profit	87,604	69,173	70,067	72,700	78,971
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	117,785	103,837	111,136	116,942	129,385
Operating Profit	23,207	10,673	9,057	11,388	12,321
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	26,155	12,197	12,956	16,113	19,186
Provision for Income Taxes
Net Income After Taxes	18,911	9,433	9,863	12,126	14,432
Minority Interest
Net Income Before Extraordinary Items
Net Income	18,694	9,251	9,659	11,743	13,971
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	18,694	9,250	9,658	11,742	13,969
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	223	111	122	147	191
Dividends per Share
Special Dividends per Share